IRIDEX Secures Large Ophthalmology Laser Equipment Tender to Supply Rural Chinese Regions
PR Newswire - Tue Dec 02, 5:30AM CST
IRIDEX Corporation (Nasdaq:IRIX) announced today that its China distributor has been awarded a competitive tender for more than $620,000 in ophthalmology laser equipment to fulfill a government program designed to provide advanced ophthalmology solutions to patients across vast areas of China's rural regions.
IRIX: 8.42 (-0.18)
IRIDEX Secures Large Tender from Government of Zambia for Ophthalmology Laser Equipment
PR Newswire - Wed Nov 19, 5:30AM CST
IRIDEX Corporation (Nasdaq:IRIX) announced today that it has been awarded a competitive tender for more than $350,000 in ophthalmology laser equipment by the government of Zambia.
IRIX: 8.42 (-0.18)
Iridex (IRIX) Upgraded From Hold to Buy
at The Street - Wed Nov 05, 8:11AM CST
Iridex (IRIX) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation:
IRIX: 8.42 (-0.18)
IRIDEX's (IRIX) CEO Will Moore on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 9:17PM CDT
IRIX: 8.42 (-0.18)
IRIDEX beats by $0.03
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 4:24PM CDT
IRIX: 8.42 (-0.18)
IRIDEX Reports 2014 Third Quarter, Nine-Month Results
PR Newswire - Thu Oct 30, 3:05PM CDT
IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the third quarter and nine months ended September 27, 2014.
IRIX: 8.42 (-0.18)
Downtrend Call Working As Iridex Stock Falls 16.2% (IRIX)
Comtex SmarTrend(R) - Thu Oct 30, 9:59AM CDT
SmarTrend identified a Downtrend for Iridex (NASDAQ:IRIX) on July 8th, 2014 at $7.92. In approximately 4 months, Iridex has returned 16.23% as of today's recent price of $6.63.
IRIX: 8.42 (-0.18)
IRIDEX Announces Third Quarter 2014 Conference Call and Release Date
PR Newswire - Thu Oct 23, 3:05PM CDT
IRIDEX Corporation (NASDAQ: IRIX) today announced that it will release its third quarter 2014 financial results after the market closes on Thursday, October 30, 2014. In conjunction with the release, the Company will host a conference call with the investment community at 5:00 p.m. Eastern Time on Thursday, October 30, 2014 to discuss the results of the quarter and other business developments.
IRIX: 8.42 (-0.18)
Iridex Down 14.1% Since SmarTrend Downtrend Call (IRIX)
Comtex SmarTrend(R) - Thu Oct 23, 9:30AM CDT
SmarTrend identified a Downtrend for Iridex (NASDAQ:IRIX) on July 8th, 2014 at $7.92. In approximately 4 months, Iridex has returned 14.09% as of today's recent price of $6.80.
IRIX: 8.42 (-0.18)
IRIDEX to Host MicroPulse® Worldwide 3-Day Forum at the American Academy of Ophthalmology
PR Newswire - Fri Oct 17, 5:30AM CDT
IRIDEX Corporation (Nasdaq:IRIX) announced today its Speakers' Forum program at the annual meeting of the American Academy of Ophthalmology to be held on October 18 - 21 at McCormick Place in Chicago. The Forum consists of a comprehensive 3-day schedule of activities at the IRIDEX booth featuring 13 MicroPulse presentations by 14 leading physicians, 8 of which are new to the IRIDEX podium.
IRIX: 8.42 (-0.18)
IRIDEX Expands Retinal Portfolio
PR Newswire - Tue Oct 14, 5:30AM CDT
IRIDEX Corporation (Nasdaq:IRIX) announced today that it will introduce its new family of patented Adjustable & Intuitive Extended Reach (A&I XR) laser probes at the annual meeting of the American Academy of Ophthalmology to be held October 18 - 21 at McCormick Place in Chicago. The A&I XR laser probes are used for laser photocoagulation during vitreoretinal procedures. These new devices offer unprecedented uniformity and consistency of treatment using both straight and angled configurations that allow the surgeon to comfortably reach all parts of the anatomy.
IRIX: 8.42 (-0.18)
IRIDEX Granted U.S. Patent for Disposable MicroPulse® Delivery Device for the Non-invasive Treatment of Glaucoma
PR Newswire - Tue Oct 07, 5:30AM CDT
IRIDEX Corporation (NASDAQ:IRIX) today announced that the United States Patent and Trademark Office granted the company a patent for a new proprietary disposable delivery device. The disposable delivery device, the first of its kind, enables ophthalmologists to administer IRIDEX' proprietary MicroPulse Laser Therapy in a unique and non-invasive way. The new disposable delivery device was developed to address a broad range of glaucoma patients and is planned to be commercially available in the first quarter of 2015.
IRIX: 8.42 (-0.18)
IRIDEX Reports Strong Attendance at European Workshop for its Proprietary MicroPulse® Laser Therapy for Retina and Glaucoma Applications
PR Newswire - Wed Oct 01, 3:05PM CDT
IRIDEX Corporation (NASDAQ: IRIX) today reported a strong physician presence and reception at this year's joint congress of the European Society of Retina Specialists (EURETINA) and European Society of Cataract and Refractive Surgeons (ESCRS) meeting in London. Among its activities at the event, IRIDEX hosted a workshop on its MicroPulse Laser Therapy to a standing room only auditorium - over 150 physicians were in attendance. In addition, the EURETINA society independently hosted an official instructional course on MicroPulse technology as part of its society curriculum.
IRIX: 8.42 (-0.18)
Iridex Has Returned 11.7% Since SmarTrend Recommendation (IRIX)
Comtex SmarTrend(R) - Wed Oct 01, 10:07AM CDT
SmarTrend identified a Downtrend for Iridex (NASDAQ:IRIX) on July 8th, 2014 at $7.92. In approximately 3 months, Iridex has returned 11.69% as of today's recent price of $6.99.
IRIX: 8.42 (-0.18)
Nasdaq stocks posting largest volume decreases
AP - Fri Sep 26, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest volume decliners on Nasdaq at the close of trading:
RGCO: 21.56 (-0.08), IRIX: 8.42 (-0.18), FCCO: 11.35 (+0.13), CBIN: 27.50 (-0.28), USBI: 8.74 (-0.01), SMBC: 37.01 (+0.01)
Director Garrett A. Garrettson, Ph.D. to Step Down After Decade-Long Service
PR Newswire - Thu Aug 07, 12:00PM CDT
IRIDEX Corporation (Nasdaq: IRIX) today announced that, after more than a decade of service, Garrett A. Garrettson has resigned his seat on the IRIDEX Board of Directors.
IRIX: 8.42 (-0.18)
IRIDEX to Present at 2014 Wedbush Life Sciences Management Access Conference
PR Newswire - Tue Aug 05, 3:05PM CDT
IRIDEX Corporation (NASDAQ: IRIX) today announced that President and CEO Will Moore is scheduled to make an investor presentation at the 2014 Wedbush Life Sciences Management Access Conference at 1:55 p.m. Eastern Time on Tuesday, August 12, in New York City. In addition, Mr. Moore will participate on a panel at the conference discussing Ophthalmology Treatments & Tools at 11:30 a.m. Eastern Time on Tuesday, August 12th.
IRIX: 8.42 (-0.18)
IRIDEX Reports 2014 Second Quarter, Six-Month Results
PR Newswire - Thu Jul 31, 3:05PM CDT
IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the second quarter and six months ended June 28, 2014.
IRIX: 8.42 (-0.18)
IRIDEX Announces Second Quarter 2014 Conference Call and Release Date
PR Newswire - Thu Jul 24, 3:05PM CDT
IRIDEX Corporation (NASDAQ: IRIX) today announced that it will release its second quarter 2014 financial results after the market closes on Thursday, July 31, 2014. In conjunction with the release, the Company will host a conference call with the investment community at 5:00 p.m. Eastern Time on Thursday, July 31, 2014 to discuss the results of the quarter and other business developments.
IRIX: 8.42 (-0.18)